Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Anyone try GHK-Cu ?

      in Question  4 upvotes 7 years ago
      GHK-Cu is discussed for its potential anti-aging and healing properties, with some users considering its effects on hair growth. One user mentions using Folligen Spray and topical finasteride, noting improved healing but uncertain hair growth results.

      community Almost 3 months on pyrilutamide

      in Treatment  32 upvotes 3 years ago
      A user's experience with Pyrilutamide, which they have been taking for 3 months to treat their aggressive male pattern baldness. The user reported that the medication decreased shedding and was hopeful it would work as advertised.

      community Losing ground on 3x a week finasteride

      in Finasteride/Dutasteride  3 upvotes 3 months ago
      The user is experiencing hair loss despite using finasteride three times a week due to side effects and is considering alternatives like topical finasteride, estrogen blockers, or dutasteride. They are also interested in potential treatments like GT20029 and pyrilutamide.

      community 5mg KX 826 Worked. Will 2.5mg Hold?

      in Technology  6 upvotes 11 months ago
      Reducing the dose of Pyrilutamide from 5mg to 2.5mg may still maintain hair loss results, but effectiveness can vary. Users discuss the cost and dosage implications, with some cautioning against reducing the dose due to its dose-dependent nature.

      community 4 months progress using 2.5mg min, 1mg fin and 10mg biotin.

      in Progress Pictures  40 upvotes 2 months ago
      A user shared their 4-month progress using 2.5mg minoxidil, 1mg finasteride, and 10mg biotin, noting slight testicular discomfort initially but no significant hairline changes yet. Another user reported similar treatment results, with hair darkening at the scalp center and small temple hairs.

      community Allergan recruiting for Setipiprant trial in the US

       12 upvotes 8 years ago
      The conversation discusses a clinical trial for Setipiprant in the US, starting June 29th, with eligibility excluding recent users of minoxidil or finasteride. It encourages informed decision-making before signing up.